BPC-157 vs a Cortisone Shot for Injury Recovery

Two Different Tools

If you have a nagging tendon or an inflamed joint, at some point someone will suggest a cortisone shot. It is one of the most common procedures in orthopedics and sports medicine for a reason. It works, and it works fast. Somewhere around the same time, if you spend any time reading about recovery, you will run into BPC-157 Explore PeRxBPC-157The Body Protection CompoundView peptide , a peptide with a growing reputation for tendon and soft-tissue repair. The natural question is which one you should get.

That framing is a little off, though. A cortisone shot and a course of BPC-157 are not two flavors of the same treatment. They target different parts of the problem. Cortisone goes after the inflammation and the pain. BPC-157 goes after the repair process itself. Understanding that difference is the whole point of this comparison, because it tells you which tool matches your actual goal.

A quick note on honesty before we go further. As of July 2026, BPC-157 is not FDA-approved, and most of what we know about it comes from animal and cell studies. It is not a cure, it does not work overnight, and no peptide fixes a serious structural tear on its own. This guide is decision-support, not a sales pitch. If you want the full background on the peptide itself, the complete BPC-157 guide Read nextBPC-157: The Complete Guide to the Body Protection CompoundA peptide discovered in a Croatian lab in the early '90s is now one of the most studied healing compounds in regenerative medicine. Here's what the science actually says, where it came from, and what you should know before starting.Read article covers the discovery story, mechanisms, and research base in depth.

What a Cortisone Shot Actually Does

Cortisone is a corticosteroid, a synthetic version of a hormone your adrenal glands make. When it is injected into or around an inflamed joint or tendon sheath, it does one thing very well: it powerfully suppresses the local inflammatory response. Inflammation is a big part of what makes an injury hurt, so damping it down often brings fast, noticeable relief. For a lot of people that relief shows up within a few days.

That speed is the whole appeal. If a flared joint is keeping you from sleeping, working, or walking normally, a cortisone shot can get you functional again quickly. It is administered by a clinician in an office visit, and for the right problem it is a genuinely useful, well-established treatment. Nothing in this guide argues against cortisone as a tool.

The catch is what cortisone does not do. Suppressing inflammation is not the same as repairing tissue. The pain signal gets quieter, but the underlying damage is still there. And here is the part that matters most for tendons: repeated corticosteroid injections into or directly around a weight-bearing tendon are associated with weakening of the tissue over time, and in some cases tendon rupture. This is why clinicians put limits on how often cortisone is injected into the same spot.

What BPC-157 Does Differently

BPC-157 (Body Protection Compound-157) is a 15-amino-acid peptide originally derived from a protective protein found in human gastric juice. Where cortisone suppresses, BPC-157 supports. It does not blunt inflammation across the board. Instead, the research points to it working with the repair process in a few connected ways.

Tendons and ligaments are slow healers for a simple reason: they have poor blood supply. Less blood flow means fewer nutrients and repair cells reaching the injury, so healing crawls. BPC-157 has been shown in animal and cell studies to promote angiogenesis, the formation of new blood vessels, which is a plausible route to speeding up repair in exactly the tissues that struggle most.

Hsieh MJ et al., "Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation," Journal of Molecular Medicine, 2017. Cell and rodent models. View study

On the tendon side specifically, a 2011 study found that BPC-157 accelerated the outgrowth of tendon explants and increased the survival and migration of tendon fibroblasts, the cells that rebuild the tissue. A follow-up study reported that BPC-157 increased growth hormone receptor expression in those same fibroblasts, which would make the repair cells more responsive to the body's own growth signals. Both are preclinical, but they line up with the regenerative story rather than the pain-suppression one.

Chang CH et al., "The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration," Journal of Applied Physiology, 2011. View study

Chang CH et al., "Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts," Molecules, 2014. View study

The practical difference is the delivery. Cortisone is a one-time in-office shot into the problem area. BPC-157 is a small daily subcutaneous injection, usually given near the injury or in the abdomen, over a course of several weeks. If needles are the sticking point, our guide on where to inject BPC-157 Read nextWhere to Inject BPC-157: Sites & TechniqueBPC-157 is a subcutaneous injection. The four standard sites all work, but the questions patients actually ask are whether to inject near the injury, how to rotate, and how to do it without a stinging welt. Here is the practical guide people want after the first vial arrives.Read article walks through sites and technique. This is not a single dramatic intervention. It is a slow accumulation of support for the repair process.

The Corticosteroid-Protection Research

Here is where the comparison gets genuinely interesting, and it is the one finding most people have never heard. In animal research, BPC-157 did not just heal tendon on its own. It appeared to protect tendon healing from the damage a corticosteroid causes.

In a 2006 rat study of Achilles tendon-to-bone healing, a corticosteroid consistently made the healing worse across the measured outcomes. BPC-157 improved that healing on its own, and when the two were given together, it substantially reduced the aggravation the corticosteroid caused. A 2008 follow-up in the same injury model found that BPC-157 supported early functional recovery and increased new blood vessel formation at the repair site, while the corticosteroid reduced that vessel formation. In other words, the peptide pushed in the opposite direction from the steroid on the exact tissue metric that matters for a healing tendon.

Krivic A et al., "Achilles detachment in rat and stable gastric pentadecapeptide BPC 157: promoted tendon-to-bone healing and opposed corticosteroid aggravation," Journal of Orthopaedic Research, 2006. View study

Krivic A et al., "Modulation of early functional recovery of Achilles tendon to bone unit after transection by BPC 157 and methylprednisolone," Inflammation Research, 2008. View study

Side-by-Side Comparison

What the BPC-157 Timeline Looks Like

One of the clearest differences between the two is how the experience unfolds over time. A cortisone shot front-loads the benefit: relief comes early and can fade later. BPC-157 is the reverse. Not much happens on day one, and the case for it builds over weeks. Here is roughly what people describe, keeping in mind that injury type, age, and consistency all move these windows around.

When Each One Makes Sense

Because these tools do different things, the decision usually comes down to what you are optimizing for right now.

These are not mutually exclusive. Some people use a cortisone shot to get an acutely painful area calm enough to function, then turn to a regenerative approach to support the tissue over the following weeks. The animal research on BPC-157 opposing corticosteroid-impaired tendon healing is part of why that sequence is even a conversation, though it remains preclinical. Whether and how to combine them is a decision for the provider managing your injury.

If you are weighing this because of a specific injury, a couple of our other guides go deeper on the situations where BPC-157 comes up most. The guide on peptides for powerlifters and joint or tendon recovery Read nextPeptides for Powerlifters and Strongman: Healing Joints and Tendons Under Maximal LoadThe SI flare four weeks out from a meet. The elbow that ends a bench cycle. How peptide therapy is used for the connective-tissue injuries that come from moving the heaviest weights you can.Read article covers heavy-load connective tissue stress, and BPC-157 for tennis and golfer's elbow Read nextBPC-157 for Tennis Elbow and Golfer's Elbow: Peptides for Elbow Tendinopathy RecoveryThe hot point on the inside or outside of the elbow that flares with every swing, throw, or hard grip. How peptide therapy is used for lateral and medial epicondylitis in tennis, golf, pickleball, climbing, disc golf, and any gripping work.Read article walks through a classic overuse tendinopathy. If you are also comparing BPC-157 against other recovery peptides, BPC-157 vs TB-500 Read nextBPC-157 vs TB-500: What Is the Difference?Both are recovery peptides. Both are popular. But they work through completely different mechanisms. BPC-157 sends the repair signals. TB-500 moves the construction crew.Read article is the head-to-head, and the pre-mixed BPC/TB-500 combination Explore PeRxBPC/TB-500The Ultimate Recovery ComboView peptide pairs both peptides in a single injection for broader repair coverage.

Frequently Asked Questions

Reviewed by Dr. Cory Mellon, MD · Last reviewed July 2026